Episode 52 of The Quantum Computing Podcast with Fexingo dives into how quantum computers are already being used to simulate molecular interactions that classical supercomputers can't handle. Lucas and Luna break down a specific case: in early 2026, a team at a major pharmaceutical company used a 127-qubit IBM system to model a protein-ligand binding pathway for an oncology target, reducing a simulation that would have taken 10,000 years on classical hardware to just under three hours. They explore what this means for drug development timelines, the limitations of current noisy qubits, and why the pharmaceutical industry is investing billions in quantum infrastructure now. No hype, just the real state of play as of June 2026.

#QuantumComputing #DrugDiscovery #Pharmaceuticals #IBM #Qubits #MolecularSimulation #ProteinLigand #Oncology #ClassicalVsQuantum #NoisyIntermediateScaleQuantum #NISQ #QuantumSupremacy #TechPodcast #BusinessPodcast #FexingoBusiness #Podcast #Innovation #Healthcare

Keep every episode free: buymeacoffee.com/fexingo